Magellan Life Sciences

Magellan Life Sciences

About

Company description

Magellan Life Sciences is a synthetic biology company that discovers and develops plant inspired proteins for commercial applications in Food and Beverage industries. Magellan’s proprietary protein production platform XSeed bridges the gap from R&D to consumer markets by allowing for economically viable industrial scale production of unique natural proteins. The sweet tasting protein Brazzein is the leading product from our pipeline. Brazzein holds significant commercial potential as the next-gen protein sweetener that is 1200 times sweeter than sugar, zero caloric, pH and heat stable. Unlike all its competitors, Brazzein has a sugar-like taste with no bitter or metallic aftertaste, thus requiring zero masking agents, thereby reducing formulation and product costs; a high value proposition for today’s F&B industry. Using XSeed, we have developed a patented commercially viable production process for Brazzein. Magellan is currently seeking strategic investment for its seed round, joint ventures and collaborations for scaling our production and commercialization of Brazzein.

Quick facts

Sales markets Western Europe; Eastern Europe; Asia; Australia; North America; Central/South America
Business segment focus Beverages
Affiliated categories: Proteins |Sweeteners More

Recently at

27 nov 2018

Hi Europe 2018

27 - 29 November 2018 Frankfurt, Germany We were at stand 8K81 See our Exhibitor Profile   See full Exhibitor List

News about Magellan Life Sciences

UK firm claims to have first commercially viable scale-up process for brazzein

3 Nov 2018

UK firm claims to have first commercially viable scale-up process for brazzein

Magellan Life Sciences says its patent-pending fermentation process to scale up the sweet-tasting protein brazzein will make it the first company to market the natural, zero-calorie sweetener.

Read more

3 Nov 2018

Startup Innovation Challenge 2018 nominees: Alternative proteins, upcycling side-streams

01 Nov 2018 --- The role of start-ups in shaping the future of the food and beverage industry is pronounced. Their role as thought leaders has driven multinational companies and legacy brands to invest in them – and learn from them: significant players are going small in their strategy. 

Read more

3 Nov 2018

Brazzein scale-up: “Nature has the answer to sugar reduction,” says Magellan Life Sciences CEO

11 Jul 2018 --- UK-based Magellan Life Sciences is scaling up their production of brazzein, through its patent-pending fermentation process. The company believes it will be the first to market the natural sweetener on a major scale. Using an FDA-approved microorganism strain and food-grade chemicals, Magellan Life Sciences has developed a unique process that promises commercial quantities of brazzein that are “identical to nature.”

Read more

Categories affiliated with Magellan Life Sciences

Magellan Life Sciences

Contact information

Address

Telephone

Website

View all contact information